Transmedics Group Inc
TMDX
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.32B
Close$
$86.08
20.6% upside
Current Fair Value
20.6% upsideUndervalued by 20.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.32 Billion |
|---|---|
| Enterprise Value | $2.68 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.6 |
| Beta | 2.06 |
| Outstanding Shares | 34,384,207 |
Return
| Return on Equity | 34.80% |
|---|---|
| Return on Assets | 11.98% |
| Return on Invested Capital | 7.55% |
Valuation & Multiples
| P/E Ratio | 13.44 |
|---|---|
| PEG | -18.79 |
| Price to Sales | 3.97 |
| Price to Book Ratio | 5.1 |
| Enterprise Value to Revenue | 4.22 |
| Enterprise Value to EBIT | 26.46 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 1.66 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$0.62
Average shareholder expectationRevenue Estimate
$174.47 M
Average shareholder expectationNext Earnings Call
Expected Date
July 29, 2026
EPS Estimate
$0.74
Average shareholder expectationRevenue Estimate
$189.61 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8504▲ 23.46% |
|---|---|
| Total Calls | 573,100▼ 15.68% |
| Total Puts | 487,385▲ 16.43% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 106.48%▼ 2.53% |
|---|---|
| Total Invested | $3.62B▼ 19.95% |
| Investors Holding | 431▼ 16.00% |
ESG Score
No data